In last trading session, Hims & Hers Health Inc (NYSE:HIMS) saw 46.68 million shares changing hands with its beta currently measuring 2.16. Company’s recent per share price level of $61.12 trading at -$2.88 or -4.50% at ring of the bell on the day assigns it a market valuation of $13.68B. That closing price of HIMS’s stock is at a discount of -19.4% from its 52-week high price of $72.98 and is indicating a premium of 78.53% from its 52-week low price of $13.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 73.53 million shares which gives us an average trading volume of 37.36 million if we extend that period to 3-months.
For Hims & Hers Health Inc (HIMS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.56. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.22 in the current quarter.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Upright in the red during last session for losing -4.50%, in the last five days HIMS remained trading in the green while hitting it’s week-highest on Wednesday, 05/14/25 when the stock touched $61.12 price level, adding 7.24% to its value on the day. Hims & Hers Health Inc’s shares saw a change of 152.77% in year-to-date performance and have moved 16.75% in past 5-day. Hims & Hers Health Inc (NYSE:HIMS) showed a performance of 115.90% in past 30-days. Number of shares sold short was 62.31 million shares which calculate 2.15 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 68 to the stock, which implies a rise of 10.12% to its current value. Analysts have been projecting 68 as a low price target for the stock while placing it at a high target of 68. It follows that stock’s current price would drop -11.26% in reaching the projected high whereas dropping to the targeted low would mean a loss of -11.26% for stock’s current value.
Hims & Hers Health Inc (HIMS) estimates and forecasts
This year revenue growth is estimated to rise 58.65% from the last financial year’s standing.
11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 549.05M for the same. And 11 analysts are in estimates of company making revenue of 584.93M in the next quarter. Company posted 315.65M and 401.56M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.22% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 25.00% while estimates for its earnings growth in next 5 years are of 35.15%.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Insiders are in possession of 11.09% of company’s total shares while institution are holding 75.09 percent of that, with stock having share float percentage of 84.46%. Investors also watch the number of corporate investors in a company very closely, which is 75.09% institutions for Hims & Hers Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at HIMS for having 16.47 million shares of worth $332.55 million. And as of 2024-06-30, it was holding 7.6746 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 14.57 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.7907 of outstanding shares, having a total worth of $294.25 million.
On the other hand, iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 6.24 shares of worth $381.69 million or 2.90% of the total outstanding shares. The later fund manager was in possession of 5.27 shares on Dec 31, 2024 , making its stake of worth around $322.21 million in the company or a holder of 2.45% of company’s stock.
